Saptalis Pharmaceuticals Launches Fluoxetine Oral Solution, USP 20 mg/5 mL

Saptalis Pharmaceuticals, LLC is pleased to announce that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Metronidazole Vaginal Gel, 0.75%. This product is the generic equivalent of MetroGel-Vaginal 0.75% by Bausch Health US, LLC. The company expects to begin shipping the product shortly through its existing distribution network.

The release as fetched from its publisher. saptalis.com ↗